← All news

IsraelResearch and clinical trials

Treating anxiety and depression in Williams syndrome: improvement in most in a 14-person series

Peer-reviewed publication

A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.

In Israel, the records of 14 people with Williams syndrome taking medication for anxiety or depression were reviewed. These people had used a group of drugs that act through serotonin. Clear improvement was seen in nine of sixteen treatment trials. Side effects were reported in two trials. No patient stopped the drug because of side effects.

What does it mean for patients and families?

Anxiety is common in Williams syndrome and can be treated. This is a small, retrospective study. Medication decisions must be made with a doctor.

Source

PubMed (Journal of Child and Adolescent Psychopharmacology): Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Individuals with Williams Syndrome.

Scientific paper: Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Individuals with Williams Syndrome. Journal of Child and Adolescent Psychopharmacology, 2026. DOI: 10.1177/10445463261451798 · PubMed 42130028

The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).

This page is translated from the Turkish original.

This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.